The 180-day cure window and possibility of a reverse split create a binary overhang: either the stock recovers above $1.00 organically (unlikely given current market cap of $70M and small float) or management effects a reverse split. Watch for any SEC or Nasdaq correspondence about the company's compliance plan. The cross-filing context (prior 20-F with strong revenue growth but governance red flags, active F-3 shelf) suggests a capital raise could accompany any reverse split, increasing dilution risk.
Price Chart
Executive Summary
Hongli Group disclosed receipt of a Nasdaq deficiency letter on July 2, 2026, for failing to maintain a minimum bid price of $1.00 over 30 consecutive business days. The company has a 180-day cure period through December 29, 2026, and may pursue a reverse stock split. This follows a prior 20-F showing strong FY2025 financials but also material internal control weaknesses and a $32.9M entrustment deposit, amplifying the delisting risk.
Key Facts
- Nasdaq notice received July 2, 2026 for bid price below $1.00 over 30 consecutive business days (May 19–July 1, 2026).
- 180-day compliance period expires December 29, 2026; closing bid must reach $1.00 for 10 consecutive days to cure.
- Company may implement a reverse stock split to regain compliance, must complete split at least 10 business days before deadline.
- Prior 20-F (filed May 13, 2026) reported FY2025 revenue of $19.6M (+39% YoY) and net income of $1.9M, but also disclosed material internal control weaknesses and a $32.9M entrustment deposit.
- Cross-filing context includes an active shelf registration (Form F-3, File No. 333-289457) allowing future capital raises.
Financial Impact
Delisting risk is material; a reverse stock split would mechanically boost share price but does not change fundamentals. Prior 20-F showed strong operational turnaround—revenue $19.6M (+39% YoY), net income $1.9M—but governance issues ($32.9M entrustment deposit, internal control weaknesses) undermine credibility.
Risk Factors
- Failure to regain compliance by December 29, 2026 could lead to delisting from Nasdaq.
- A reverse stock split may not address underlying business issues and could depress liquidity.
- Material internal control weaknesses and a large entrustment deposit ($32.9M) disclosed in prior 20-F raise governance concerns.
- An active shelf registration (F-3) creates overhang for potential dilutive offerings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-076787 |
| Document: ea029712201ex99-1.htm | 0001213900-26-076787 |
| Document: 0001213900-26-076787-index-headers.html | 0001213900-26-076787 |
| Document: 0001213900-26-076787-index.html | 0001213900-26-076787 |
| Document: 0001213900-26-076787.txt | 0001213900-26-076787 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | Press Release | $2.82 | awaiting T+60 | — | $3.50 (+24.11%) |
Oct 5, 2026 21d ago | 6-K | $2.52 | awaiting T+60 | — | $3.50 (+38.89%) |
Jul 30, 2026 12w ago | 6-K | $1.23 $3.50 | ▲ +184.55% | ▲ +182.10% | $3.50 (+184.55%) |
Jul 9, 2026 15w ago | 6-K | $1.17 $2.47 | ▼ −111.11% | ▼ −108.48% | $3.50 (−199.15%) |
Jun 11, 2026 19w ago | 6-K | $0.5000 $1.40 | ▼ −179.00% | ▼ −175.74% | $3.50 (−600.00%) |
May 15, 2026 23w ago | 6-K | $1.03 $1.30 | ▲ +26.21% | ▲ +21.70% | $3.50 (+239.81%) |
May 13, 2026 23w ago | 20-F | $1.16 $1.30 | ▲ +12.07% | ▲ +7.63% | $3.50 (+201.72%) |
May 13, 2026 23w ago | 6-K | $1.16 $1.30 | ▲ +12.07% | ▲ +7.63% | $3.50 (+201.72%) |
Apr 16, 2026 27w ago | 6-K | $1.11 $1.11 | · 0.00% | ▼ −6.14% | $3.50 (+215.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers